Production (Stage)
E
Beta Bionics, Inc. BBNX
$14.43 -$1.08-6.96% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024
Total Cash And Short-Term Investments 139.26% 7.06% --
Total Receivables -- 169.69% --
Inventory -- 969.88% --
Prepaid Expenses -- 228.41% --
Finance Division Loans and Leases Current -- -- --
Total Finance Division Other Current Assets -- -- --
Other Current Assets -- 281.82% --
Total Current Assets -- 28.28% --

Total Current Assets -- 28.28% --
Net Property, Plant & Equipment -- 84.27% --
Long-term Investments -- -- --
Goodwill -- -- --
Total Other Intangibles -- -- --
Finance Div Loans & Leases LT -- -- --
Total Finance Div Other LT Assets -- -- --
Total Other Assets -- 2,298.64% --
Total Assets -- 35.99% --

Total Accounts Payable -- 144.60% --
Total Accrued Expenses -- 88.46% --
Short-term Debt -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- --
Finance Division Debt Current -- 24.92% --
Total Finance Division Other Current Liabilities -- 201.05% --
Total Other Current Liabilities -- 201.05% --
Total Current Liabilities -- 99.42% --

Total Current Liabilities -- 99.42% --
Long-Term Debt -- -- --
Short-term Debt -- -- --
Capital Leases -- 90.93% --
Finance Division Debt Non Current -- -- --
Total Finance Division Other Non Current Liabilities -- -- --
Total Other Liabilities -- 23.61% --
Total Liabilities -- 43.16% --

Common Stock & APIC -- 94.20% --
Retained Earnings -- -29.20% --
Treasury Stock & Other -- -52.55% --
Total Common Equity 254.48% -20.80% --

Preferred Stock Redeemable -- -- --
Preferred Stock Non Redeemable -- -- --
Preferred Stock Convertible -- 22.80% --
Preferred Stock, Others -- -- --
Total Preferred Equity -- 22.80% --

Total Common Equity 254.48% -20.80% --
Total Preferred Equity -- 22.80% --
Total Minority Interest -- -- --
Total Equity 435.34% 29.70% --